NIFFENEGGER KATHI
Known title: Chief Financial OfficerCIK: 0001620146
Associated companies
Transaction History
| EDSA | ▲ Buy | Grant | 8,888 | $10K | 11/2/2022 | View on chart |
| EDSA | ▲ Buy | Grant | 8,888 | $10K | 11/2/2022 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
Edesa Biotech Included in After-Market Movers List
Edesa Biotech was highlighted in a recent list of healthcare stocks showing movement during Thursday's after-market session. The company trades well below its average analyst price target, with a 52-week range spanning from $0.72 to $20.32. This inclusion suggests increased attention from traders monitoring after-hours activity in the sector.
Edesa Biotech Included in After-Market Movers List. Edesa Biotech was highlighted in a recent list of healthcare stocks showing movement during Thursday's after-market session. The company trades well below its average analyst price target, with a 52-week range spanning from $0.72 to $20.32. This inclusion suggests increased attention from traders monitoring after-hours activity in the sector.